From the second half of 2024, it will process full capacity of up to 1 kg of cannabis per day, resulting in 000 kg of pure active ingredients per day.

First and foremost, the certification and the THC content. Our non-GMP products all have a THC content of less than 1%. Our API or cannabis medicines may also have a higher content. In addition, the API/cannabis medicines are manufactured strictly in accordance with the EU GMP regulations as well as the European, German and Swiss pharmacopoeia.

Our non-GMP products are also manufactured at the same location, but are not subject to such strict regulations. Of course, our non-GMP products are also of the highest quality; This is absolutely sufficient for food and cosmetics, just not for pharmaceuticals.

The construction of the building was completed in July 2022, and the systems have also been installed since March 2023. This means that the new facility will begin operating fully from April 2023.

No, according to the current legal situation in Switzerland, cannabis extracts are only available through pharmacies and with a doctor's prescription.

Of course, one can argue about the sense and nonsense of requiring a prescription for products with less than 1% THC, but from a legal perspective there is currently no major basis for discussion. In any case, we welcome the dispensing of medicines via the pharmacy, as this can ensure quality. This is particularly important in the still young cannabis market. We also advise against purchasing products from online shops, as these products are generally not approved and the quality cannot be guaranteed.